Insulin-like growth factor-1 effects on bovine retinal endothelial cell glucose transport: role of MAP kinase
dc.contributor.author | DeBosch, Brian J. | en_US |
dc.contributor.author | Deo, Baljit K. | en_US |
dc.contributor.author | Kumagai, Arno K. | en_US |
dc.date.accessioned | 2010-04-01T14:55:42Z | |
dc.date.available | 2010-04-01T14:55:42Z | |
dc.date.issued | 2002-05-15 | en_US |
dc.identifier.citation | DeBosch, Brian J . ; Deo, Baljit K . ; Kumagai, Arno K . (2002). "Insulin-like growth factor-1 effects on bovine retinal endothelial cell glucose transport: role of MAP kinase." Journal of Neurochemistry 81(4): 728-734. <http://hdl.handle.net/2027.42/65385> | en_US |
dc.identifier.issn | 0022-3042 | en_US |
dc.identifier.issn | 1471-4159 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/65385 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12065632&dopt=citation | en_US |
dc.description.abstract | In order to maintain normal metabolism, the neuroretina is completely dependent on the constant delivery of glucose across the retinal microvascular endothelial cells comprising the inner blood–retinal barrier. Glucose uptake into these cells is influenced by various stimuli, including hypoxia and growth factors. Recently, insulin-like growth factor-1 (IGF-1) was shown to enhance retinal endothelial glucose transport in a process that is dependent on protein kinase C (PKC) and phosphatidylinositol-3 kinase (PI3 kinase). In the current study, the role of mitogen-activated protein kinase (MAP kinase) in regulating IGF-1 effects on retinal endothelial cell glucose transport was investigated in a bovine retinal endothelial cell (BREC) culture model. IGF-1 (25 ng/mL) caused a rapid increase in MAP-kinase activity and ERK phosphorylation. Inhibition of MAP kinase with PD98059 (100 µm) blocked IGF-1 enhancement of 2-deoxyglucose uptake. In order to clarify the relationship between PKC, PI3 kinase and MAP kinase in IGF-1 signaling in retinal endothelial cells, the effects of selective inhibitors of MAP kinase (PD98059), PKC (GF109203X), and PI3 kinase (wortmannin, LY294002) on signal transduction by IGF-1 were studied. Inhibition of MAP kinase abolished IGF-1 stimulation of PKC but had no effect on PI3 kinase activity, whereas inhibition of either PKC and PI3 kinase had no effect on MAP kinase phosphorylation or activity in IGF-1-treated cells. Taken together, these data demonstrate that IGF-1 stimulation of BREC glucose transport requires activation of MAP kinase and that MAP kinase is upstream from PKC but is independent of PI3 kinase in mediating the actions of IGF-1 on retinal endothelial cells. | en_US |
dc.format.extent | 237062 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Ltd | en_US |
dc.rights | 2002 International Society for Neurochemistry | en_US |
dc.subject.other | Diabetic Retinopathy | en_US |
dc.subject.other | Glucose Transport | en_US |
dc.subject.other | GLUT1 | en_US |
dc.subject.other | Inner Blood–Retinal Barrier | en_US |
dc.subject.other | Insulin-like Growth Factor | en_US |
dc.subject.other | Retinal Endothelial Cells | en_US |
dc.title | Insulin-like growth factor-1 effects on bovine retinal endothelial cell glucose transport: role of MAP kinase | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | † Michigan Diabetes Research & Training Center and | en_US |
dc.contributor.affiliationum | † JDRF Center for Complications in Diabetes, University of Michigan Medical School, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | * Department of Internal Medicine, | en_US |
dc.identifier.pmid | 12065632 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/65385/1/j.1471-4159.2002.00848.x.pdf | |
dc.identifier.doi | 10.1046/j.1471-4159.2002.00848.x | en_US |
dc.identifier.source | Journal of Neurochemistry | en_US |
dc.identifier.citedreference | Alessi D. R., Cuenda A., Cohen P., Dudley D. T. and Saltiel A. R. ( 1995 ) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem 270, 27489 – 27494. | en_US |
dc.identifier.citedreference | Chakravarthy M. V., Abraha T. W., Schwartz R. J., Fiorotto M. L. and Booth F. W. ( 2000 ) Insulin-like Growth Factor-I Extends in Vitro Replicative Life Span of Skeletal Muscle Satellite Cells by Enhancing G1/S Cell Cycle Progression via the Activation of Phosphatidylinositol 3′-Kinase/Akt Signaling Pathway. J. Biol. Chem. 275, 35942 – 35952. | en_US |
dc.identifier.citedreference | Cunha-Vaz J. G. ( 1976 ) The blood–retinal barriers. Doc. Ophthal. 41, 287 – 327. | en_US |
dc.identifier.citedreference | DeBosch B. J., Deo B. K., Baur E., Deo B. K., Hiraoka M. and Kumagai A. K. ( 2001 ) Effects of Insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation. J. Neurochem. 77, 1157 – 1167. | en_US |
dc.identifier.citedreference | English J., Pearson G., Wilsbacher J., Swantek J., Karandikar M., Xu S. and Cobb M. H. ( 1999 ) New insights into the control of MAP kinase pathways. Exp. Cell Res. 253, 255 – 270. | en_US |
dc.identifier.citedreference | Heasley L. E. and Johnson G. L. ( 1989 ) Regulation of protein kinase C by nerve growth factor, epidermal growth factor, and phorbol esters in PC12 pheochromocytoma cells. J. Biol. Chem 264, 8646 – 8652. | en_US |
dc.identifier.citedreference | Knott R. M., Robertson M., Muckersie E. and Forrester J. V. ( 1996 ) Glucose-mediated regulation of GLUT-1 and GLUT-3 mRNA in human retinal endothelial cells. Biochem. Soc. Trans. 24, 216S. | en_US |
dc.identifier.citedreference | Kumagai A. K. ( 1999 ) Glucose transport in brain and retina: implications in the management and complications of diabetes. Diab. Metab. Res. Rev. 15, 261 – 273. | en_US |
dc.identifier.citedreference | Mandarino L. J., Finlayson J. and Hassell J. R. ( 1994 ) High glucose downregulates glucose transport activity in retinal capillary pericytes but not endothelial cells. Invest. Ophthalmol. Vis. Sci. 35, 964 – 972. | en_US |
dc.identifier.citedreference | Mantych G. J., Hageman G. S. and Devaskar S. U. ( 1993 ) Characterization of glucose transporter isoforms in the adult and developing human eye. Endocrinology 133, 600 – 607. | en_US |
dc.identifier.citedreference | Milasincic D., Calera M., Farmer S. and Pilch P. F. ( 1996 ) Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol. Cell. Biol. 16, 5964 – 5973. | en_US |
dc.identifier.citedreference | Robinson G. S. and Aiello L. P. ( 1998 ) Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow. Int. Ophthalmol Clin. 38, 89 – 102. | en_US |
dc.identifier.citedreference | Seger R. and Krebs E. G. ( 1995 ) The MAPK signaling cascade. FASEB J. 9, 726 – 735. | en_US |
dc.identifier.citedreference | Sone H., Deo B. K. and Kumagai A. K. ( 2000 ) Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest. Ophthalmol. Vis. Sci. 41, 1876 – 1884. | en_US |
dc.identifier.citedreference | Takagi H., King G. L. and Aiello L. P. ( 1998 ) Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes 47, 1480 – 1488. | en_US |
dc.identifier.citedreference | Takata K., Hirano H. and Kasahara M. ( 1997 ) Transport of glucose across the blood–tissue barriers. Int. Rev. Cytol. 172, 1 – 53. | en_US |
dc.identifier.citedreference | Tsakiridis T., McDowell H. E., Walker T., Downes C. P., Hundal H. S., Vranic M. and Klip A. ( 1995 ) Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology 136, 4315 – 4322. | en_US |
dc.identifier.citedreference | Vlahos C. J., Matter W. F., Hui K. Y. and Brown R. F. ( 1994 ) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241 – 5248. | en_US |
dc.identifier.citedreference | Xia P., Aiello L. P., Ishii H., Jiang Z. Y., Park D. J., Robinson G. S., Takagi H., Newsome W. P., Jirousek M. R. and King G. L. ( 1996 ) Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest. 98, 2018 – 2026. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.